Long-term Effects of COVID-19 in Adolescents
NCT04686734 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 516
Last updated 2022-07-25
Summary
The overarching objective for this prospective cohort study of COVID-19 in adolescents is to study the long-term effects, with particular emphasis on post-infectious chronic fatigue. A total of 500 individuals with a SARS-CoV-2 positive test will be enrolled in the acute phase of COVID-19 and followed for 6 months. A total of 100 individuals with SARS-CoV-2 negative test will be included during the same time period as a control group. Investigations include autonomic, pulmonary and cognitive assessement; a questionnaire charting symptoms, emotionality, personality, loneliness, life events and demographics; and extensive biobanking including genetic markers, viable PBMC, urine, feces and hair. A subgroup of 40 SARS-CoV-2 positive and 20 SARS-CoV-2 negative individuals will also undergo detailed cardiological examination by echocardiography. Primary endpoints are fatigue at 6 months as assessed by the Chalder Fatigue Scale and post-COVID-19 syndrome cases at 6 months according to the WHO definition
Conditions
- Covid19
Interventions
- OTHER
-
No active intervention (observational only)
No active intervention (observational only)
Sponsors & Collaborators
-
University Hospital, Akershus
lead OTHER
Principal Investigators
-
Vegard B Wyller, PhD · University Hospital, Akershus
Eligibility
- Min Age
- 12 Years
- Max Age
- 25 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-06
- Primary Completion
- 2022-02-02
- Completion
- 2022-06-24
Countries
- Norway
Study Locations
More Related Trials
-
In Utero Exposure to SARS-CoV-2 (COVID-19) and Cardiovascular and Metabolic Endpoints in Early Life
NCT04921241 ·Status: COMPLETED
-
COPE - COVID-19 in Pregnancy and Early Childhood
NCT04433364 ·Status: ACTIVE_NOT_RECRUITING
-
Description of Immunologic, Enzymatic and Metabolic Biomarkers Associated to the Severity of COVID-19 (SARS-CoV-2) and Its Resolution
NCT04664023 ·Status: COMPLETED
-
Prevalence of Covid-19 in Children Admitted to Paediatric Emergency Departments During the Pandemic Period in France
NCT04336761 ·Status: COMPLETED
-
Clinical Evaluation of Rapid RNA Test for Covid-19
NCT05308550 ·Status: COMPLETED ·Phase: NA
-
COVID Infection in Pediatric Surgical Patient
NCT05898529 ·Status: RECRUITING
-
COVID-19 Pregnancy Related Immunological, Clinical and Epidemiological Factors and Perinatal Outcomes
NCT04659759 ·Status: COMPLETED
-
Demographics and Outcomes of COVID 19 in Pregnancy at a Community Based Hospital
NCT04385914 ·Status: UNKNOWN
-
Seroprevalence of SARS-Cov-2 Antibodies in Children
NCT04347408 ·Status: COMPLETED
-
The CHILD Cohort COVID-19 Add-On Study
NCT05234359 ·Status: COMPLETED
-
Study of the Kinetics of COVID-19 Antibodies for 24 Months in Patients With Confirmed SARS-CoV-2 Infection
NCT04750720 ·Status: COMPLETED ·Phase: NA
-
Evaluating Clinical Parameters of COVID-19 in Pregnancy
NCT04470583 ·Status: UNKNOWN
-
Antiviral T Lymphocyte Immunity During Acute COVID-19 Infection
NCT04707820 ·Status: COMPLETED ·Phase: NA
-
COVID Booster in Pregnancy and Lactation
NCT05543993 ·Status: COMPLETED
-
Differences Between Women With COVID-19 and Long Covid
NCT05669235 ·Status: COMPLETED
-
Impact of COVID-19 Infection During Pregnancy on Newborns and Young Children
NCT04432779 ·Status: TERMINATED
-
COVID-19 Child Health Investigation of Latent Disease in Hamburg
NCT04534608 ·Status: UNKNOWN
-
Evaluation of the Acceptance of the Anti-COVID-19 Vaccine Offer Among Pregnant Women
NCT05729191 ·Status: COMPLETED
-
Clinical Usefulness of a Multi-analyte Immunoassay for Distinguishing Bacterial and Viral Infections in Children
NCT06852846 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA
-
Prospective Monitoring of Antibody Response Following COVID-19 Vaccination in Patients With Down Syndrome.
NCT05145348 ·Status: UNKNOWN
-
Evaluation of Humoral Immunity Following COVID-19 in Pregnancy
NCT04568044 ·Status: ACTIVE_NOT_RECRUITING
-
Containment Impact on Primary Care & Adverse Events Unrelated to COVID-19 in Older Patients and/or With Chronic Diseases
NCT04907994 ·Status: UNKNOWN
-
Characteristics of COVID-19 Infection Among PREGnant Women
NCT04398264 ·Status: COMPLETED
-
Assessment of Obstetric, Fetal and Neonatal Risks and Vertical SARS-CoV-2 Transmission During COVID-19 Pandemic
NCT04360811 ·Status: COMPLETED ·Phase: NA
-
SARS-CoV2 Antibodies in Pediatric Patients (COVID-19)
NCT04581148 ·Status: UNKNOWN